ID   DEOC-1
AC   CVCL_4161
SY   DEOC1
DR   CLO; CLO_0050137
DR   EFO; EFO_0006563
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472898
DR   Cosmic; 874387
DR   Cosmic; 1007159
DR   EGA; EGAS00001000610
DR   PharmacoDB; DEOC1_287_2019
DR   RCB; RCB2831
DR   Wikidata; Q54830977
RX   PubMed=17547717;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Japanese.
CC   Doubling time: 81.2 hours (Note=At 6th passage), 100 hours (Note=At 20th passage) (PubMed=17547717).
CC   HLA typing: A*24:02,26:01; B*40:02,52:01; C*03:04,12:02 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Heel, skin; UBERON=UBERON_0015873.
ST   Source(s): PubMed=25877200; RCB
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 21
ST   D21S11: 29,32
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 19,26
ST   Penta D: 9,11
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 19
//
RX   PubMed=17547717; DOI=10.1111/j.1749-0774.2007.00028.x;
RA   Maeshima S., Yamada T., Kiyokane K., Mori H.;
RT   "Establishment and characterization of a cell line (DEOC-1)
RT   originating from a human malignant melanoma of the skin.";
RL   Hum. Cell 20:23-38(2007).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//